David Campbell

6PUBLICATIONS
14CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisBehavioural geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 30, 2026
Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States.

|Jan 31, 2026
Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia.

Mazyar Shadman, Asher Chanan-Khan, David Campbell

|Sep 13, 2025
Diagnosis, Treatment, and Unmet Needs of Dedifferentiated Liposarcoma in the United States: A Multidisciplinary Delphi Study.

David Campbell, Scott Ramsey, David Veenstra

|Jul 25, 2025
A Value Framework for Evaluating Population Genomic Programs: A Mixed Methods Approach.

David Campbell, Scott Spencer, Ashley Kang

|Apr 01, 2021
Primary Prophylaxis With Biosimilar Filgrastim for Patients at Intermediate Risk for Febrile Neutropenia: A Cost-Effectiveness Analysis.

Edward Li, Dylan J Mezzio, David Campbell

|Nov 28, 2018
The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions.

David Campbell, Ken O'Day, Nadine Hertel

Pageof 1

Frequent Collaborators

2 joint publications

Constantine S Tam

1 joint publications

Edward Li

1 joint publications

Gary H Lyman

1 joint publications

Ashley Kang